- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06225180
Review of Breast Abscess Management
March 20, 2026 updated by: Methodist Health System
Breast abscesses are an unfortunate pathology that develop in patients, and treatment is often painful and unpleasant.
The goal of this study is to identify risk factors associated with failure of aspiration as a primary intervention as opposed to incision and drainage in the hopes of adequately treating patients at initial presentation.
Study Overview
Status
Terminated
Conditions
Detailed Description
The pendulum has now swung toward minimally invasive aspiration as the primary treatment modality, with multiple studies reporting superior cosmetic results.
However, patients in these studies often required repeat breast aspirations, and sometimes ultimately required incision and drainage.
Aspiration first for treatment of breast abscess may not be a wise choice for all patients if it results in increased antibiotic days, return to emergency department (ED)/increased cost, or prolonged pain from multiple procedures.
Several studies have identified varying risk factors for aspiration failure as primary intervention for breast abscesses.
More data is needed to confirm the true risk factors for failure.
Study Type
Observational
Enrollment (Actual)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Methodist Dallas Medical Center
-
Dallas, Texas, United States, 75203
- Clinical Research Institute at Methodist Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
18 years of age
• New diagnosis of N61.1 recorded in their EMR
Description
Inclusion Criteria:
• ≥18 years of age
- New diagnosis of N61.1 recorded in their Electronic Medical Record (EMR)
Exclusion Criteria:
• <18 years of age
- Pregnant
- Incarcerated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of repeat interventions prior to resolution of abscess(s)
Time Frame: 5 years
|
Determine the superiority of aspiration vs incision as primary intervention in treatment of breast abscesses
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Antibiotic days
Time Frame: 5 years
|
number of days used antibiotics
|
5 years
|
|
Repeat aspiration
Time Frame: 5 years
|
Frequency of aspiration
|
5 years
|
|
Return to Emergency Department ( ED)
Time Frame: 5 years
|
Number of times of ED visit
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Conner McDaniel, MD, Methodist Midlothian Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 29, 2023
Primary Completion (Actual)
June 12, 2025
Study Completion (Actual)
June 12, 2025
Study Registration Dates
First Submitted
November 14, 2023
First Submitted That Met QC Criteria
January 16, 2024
First Posted (Actual)
January 25, 2024
Study Record Updates
Last Update Posted (Actual)
March 24, 2026
Last Update Submitted That Met QC Criteria
March 20, 2026
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 021.TRA.2023.D
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Abscess
-
University of RochesterNot yet recruitingBreast AbscessUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinWithdrawn
-
Quaid-e-Azam Medical CollegeCompleted
-
GSVM Medical CollegeCompleted
-
Centre Hospitalier Universitaire de la GuadeloupeCompleted
-
Assiut UniversityNot yet recruitingLiver Abscess, Pyogenic
-
Hospital Italiano de Buenos AiresUnknownLiver Transplant AbscessArgentina
-
Inje UniversityPusan National University Yangsan HospitalCompletedCryptogenic Pyogenic Liver AbscessKorea, Republic of
-
Kaohsiung Veterans General Hospital.BayerCompletedLiver AbscessTaiwan
-
Manchester University NHS Foundation TrustUniversity of Liverpool; University of Birmingham; National Institute for Health... and other collaboratorsCompletedPerianal Abscess | Perianal Infections | Peri Rectal Abscess | Abscess; Anus | Abscess AnorectalUnited Kingdom